Purchase Order 75N95023P00543
- Not listed
- This is a $97,106.08 firm fixed price purchase order award by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Virscidian Inc. for the renewal of a subscription to the Virscidian Analytical Studio Express - Instrument Agent software package. The award is non-competitive and was issued without full and open competition due to exclusive licensing agreements for this...
- This is a firm fixed price purchase order award from the National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Virscidian Inc., a for-profit software company, for the Virscidian Analytical Studio Express - Instrument Agent software package. The $97,106.08 award has a completion date of August 31, 2020 and is a non-competitive sole source contract with no set-aside designation. The solicitation was specifically for this software package, which provides...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $197,126.08 firm fixed price purchase order to Virscidian Inc., a for-profit organization, for the renewal of the Virscidian Analytical Studio Express - Instrument Agent software subscription. This contract, which has no set-aside designation, provides a one-year software subscription with an option for a second year. Virscidian Inc. is a company that...
- This is a $15,944 firm fixed price purchase order awarded to Virscidian Inc. by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services. The contract is for the provision of a professional floating license subscription for Virscidian's Analytical Studio software package, which provides customized analytical software solutions. This award has no set-aside designation and is a continuation of prior awards to Virscidian...
- The U.S. Food and Drug Administration (FDA) awarded a $633,133.00 firm-fixed-price purchase order contract to Virscidian Inc., a small business, for the provision of Analytical Studio Express Software and Support. The contract has a completion date of May 26, 2015 and was awarded on May 26, 2011. Virscidian Inc. is a company that specializes in customized analytical software solutions, and this contract is part of a larger set of awards the company has received from the Department of Health...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,634.80 firm-fixed-price purchase order to National Instruments Corporation for a one-year renewal of a proprietary system design software license subscription. The original sole-source solicitation sought a 12-month license for software to perform custom algorithmic analysis of images from high-content screening devices and compound plate quality control,...
- This is a $112,000.00 Firm Fixed Price federal contract awarded by the Food and Drug Administration (FDA) to Virscidian Inc., a small business contractor, for the development of analytical studio software. The contract has a period of performance through September 20, 2016. Virscidian Inc. specializes in customized analytical software solutions and has received multiple prior contract awards from the National Institutes of Health National Center for Advancing Translational Sciences for the...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Revvity Signals Software, Inc. for the subscription to ChemDraw Professional and ChemBioOffice Enterprise Suite software. The contract has a potential value of $170,733.20 and a period of performance from January 1, 2019 through December 31, 2023. The software is used by NCATS to process and analyze research...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,900 firm fixed price purchase order to Genedata (Usa), Inc. to renew software licenses, maintenance, and support for the Genedata Analyst bioinformatics analysis program. The original sole source solicitation indicated the Analyst module is used by the Viral Pathogenesis and Evolution Section to perform statistical modeling and data visualization for vaccine and infection research studies. No...
- This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to Altoris, Inc., a technology consulting company, for an annual subscription to the SARvision SM software. The contract has a ceiling value of $22,500.00 and was awarded on May 11, 2020, with a period of performance through May 11, 2021. Altoris, Inc. is the sole source provider of the required SARvision SM...
This is a $209,130 firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Virscidian Inc. for a 1-year subscription to the Virscidian Analytical Studio Express - Instrument Agent software with an option for an additional 1-year subscription. The contract has no set-aside designation and is a sole source award, as Virscidian Inc. is the exclusive provider of this proprietary software. This award is a renewal of prior sole source contracts with Virscidian Inc. in 2021 ($197,126), 2020 ($97,106), and 2019 ($97,106) for the same software subscription and packages. NCATS, a part of NIH, has a mission to catalyze the development of innovative medical diagnostic and therapeutic technologies.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Analytical Studio - Professional Subscription | 75N95023Q00538 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Special Notice 1/1 | 7/21/23, 8:24 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $106.1k | 7/18/24 | |
| Not listed | Not listed | $103.0k | 8/9/23 |